Brief: Erytech Announces Approval To Transfer Its Listing To The Nasdaq Capital Market

Phaxiam Therapeutics SA

17/04/2023 21:07

April 17 (Reuters) - Erytech Pharma SA  ERYP.PA :
    * REG-ERYTECH ANNOUNCES APPROVAL TO TRANSFER ITS LISTING TO
THE
NASDAQ CAPITAL MARKET
    * COMPANY’S ADSS CONTINUE TO TRADE UNDER THE SYMBOL “ERYP”
AND
TRADING OF ITS ADSS WILL BE UNAFFECTED BY THIS TRANSFER

Source text for Eikon:  ID:nGNE9nqGYg 
Further company coverage:  ERYP.PA 

 ((reuters.briefs@thomsonreuters.com;))